Why Bank Shares Are Trading Lower? Here Are Other Stocks Moving In Monday’s Mid-Day Session
Gainers
Provention Bio, Inc. (NASDAQ: PRVB) shares jumped 250.8% to $23.50 after Sanofi announced it will acquire the company for $25 per share in cash.
Regional Bank Stocks Getting Crushed Monday: Here Are 19 Stocks Down 10% Or More
The collapse of Silicon Valley Bank (NASDAQ: SIVB) last week has sent the banking sector into a spiral, with the government stepping in to help backstop depositors. The news has regional banking stocks trading down significantly on Monday. Here’s what you need to know and the major movers.
Stocks React To February Jobs Report: The Winners And Losers
The markets have offered investors a rollercoaster ride this week, with a flurry of activity and developments that have sent shockwaves through various sectors.
Earnings Scheduled For January 20, 2023
Companies Reporting Before The Bell
• Telefonaktiebolaget L M (NASDAQ:ERIC) is likely to report quarterly earnings at $0.21 per share on revenue of $7.50 billion.
Schlumberger, Nordstrom And 3 Stocks To Watch Heading Into Friday
With US stock futures trading higher this morning on Friday, some of the stocks that may grab investor focus today are as follows:
Fear & Greed Index Moves To ‘Neutral’ Zone As Dow Drops For Third Day
The CNN Money Fear and Greed index moved to a "Neutral" zone after US stocks closed lower on Thursday.
The Dow Jones recorded losses for the third session in a row after investors grew concerned that the Fed will continue increasing interest rates despite signs of easing inflation.
Benzinga’s Top Ratings Upgrades, Downgrades For December 13, 2022
Upgrades For Equinix Inc (NASDAQ:EQIX), Cowen & Co. upgraded the previous rating of Market Perform to Outperform. In…
9 Analysts Have This to Say About Huntington Bancshares
Over the past 3 months, 9 analysts have published their opinion on Huntington Bancshares (NASDAQ:HBAN) stock. These analysts…
Morgan Stanley Maintains Equal-Weight on Huntington Bancshares, Raises Price Target to $16
Morgan Stanley analyst Betsy Graseck maintains Huntington Bancshares (NASDAQ:HBAN) with a Equal-Weight and raises the price target from $15 to $16.